IVIG-Associated Maternal Pancytopenia during Treatment for Neonatal Alloimmune Thrombocytopenia

• Egile Nagusiak: Alyssa Herrmann (Egilea), Benjamin J. Samelson-Jones (Egilea), Sami Brake (Egilea), Renee Samelson (Egilea)
• Formatua: Liburua
• Argitaratua: Thieme Medical Publishers, Inc., 2017-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Treatment for neonatal alloimmune thrombocytopenia (NAIT) primarily involves maternal administration of intravenous immunoglobulin (IVIG) therapy and prednisone according to protocols based on risk stratification. While IVIG is generally well tolerated, hematologic side effects a...